Former president Jacob Zuma was never going to remain the all-powerful and omnipresent political figure that he thought, writes Pieter du Toit.
The pharmacy group has been hit by a strike and a tough December.
After 35 years of mediocre depression drugs, pharmaceutical companies are jazzed about several new drugs inspired by the club drug ketamine.
Aspen Pharmacare has received approval from the China Food and Drug Administration to register its Aspen infant milk formula Alula in China.
Ascendis Health has finalised a number of European acquisitions in recent months which are expected to boost profit margins in 2018.
Aspen says it has not hiked product prices outside the regulatory framework and sees a Competition Commission probe as an opportunity to have allegations against it set aside.
India is facing immense pressure from the United States and its multinational pharmaceutical corporations lobby to roll back its pro-public health patent rules.
US drug firm Valeant has suffered its worst day ever amid a $600m typo in a press release which caused its leading investor to lose $1.2bn in a 51% stock drop.
A new test that can detect both HIV and hepatitis viruses has been approved by US authorities.
The Competition Commission has approved the merger of the Alpha Pharm group of regional pharmaceutical distributors into a single national company.
The Europe Union and drugmakers are about to invest 280 million euros into Ebola research, mainly for testing and manufacturing of potential vaccines.
Jeff Jonas says the new drug could help depressed people feel well "with just a two week course of treatment", similar to how antibiotics are used.
Dis-Chem Pharmacies reported disappointing results on Friday, but the share started falling the day before the numbers were released.
The pricing of all life-saving medicines - and not just cancer drugs - should be investigated by the Competition Commission, urges a healthcare body.
Regulators in the European Union say they’ll check that Aspen Pharmacare conducted "so-called price-gouging" by imposing price increases of up to several hundred percent.
The Compounding Pharmacy of SA is reintroducing an individually focused service, combining it with the latest medical knowledge and state-of-the-art technology.
Clicks has forecast higher earnings, citing expectations that demand for its products will remain resilient despite a weakening outlook for consumer spending.
Dr Jonathan Moch, psychiatrist and self-professed professional student of the mind, body and relationships, delves into the common factor of successful businesses.
India's Supreme Court has rejected German drugmaker Bayer's plea to block production of a cheaper generic version of a patented cancer drug.
The Indian government underestimates the number of fake drugs produced in the country, commonly passed off to Indian consumers as genuine and sold around the world.
Swiss pharmaceutical group Novartis has reported that its net profit has risen in the third quarter, on the back of growing business in emerging economies.
MosselbaaiCalandria Labour Consultants
Somerset WestAfrica Experience Collection (PTY) LTDR40 000.00 - R70 000.00 Per Month
R 11 800 000
R 2 960 000
R 2 350 000
We subscribe to the Press Code.
You choose what you want
News24 on Android
Get the latest from News24 on your Android device.
Terms and Conditions
24.com Terms and Conditions - Updated April 2012
Creating your profile will enable you to submit photos and stories to get published on News24.
This username must be unique, cannot be edited and will be used in the URL to your profile page across the entire 24.com network.